Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > Q2 siascopy sales per sedar
View:
Post by Dunworkin2 on Aug 25, 2021 3:29pm

Q2 siascopy sales per sedar

Three Months Ended June 30 2021:
SIAscopy $ 20,641
Phototherapeutic lasers $ 125,891
Total $ 146,532

$20,641 in SiaScopy sales!!!!!! .....that's it, so $20,641 divided by 90 days = $ 229.34 per day in Siascopy sales this quarter. 

WTF is this sales team doing? Stop playing solitaire and sell some product.....or maybe there is no future in this product which could be the harsh reality. Remember that MDX hired the creme de la creme sales team. Approved in over 35 countries, right?.... and we have $ 229.34 per day in sales! 

Burning about $ 1 million a quarter and Sedar showed $1.8 million in cash at June 30, so will be needing more money soon.

Sylvain will have his work cut out for him. Bon chance mon ami!
Comment by hopefull on Aug 25, 2021 6:31pm
looking at the past interviews I believe Mike has seriously missed the mark, and completely misled us stating revenues would follow especially with the Netherlands. Really looks like Derm tech is the leader in this space. Would be nice for some honesty from this group but alas this is very telling. Sylvain really has to address investors concerns if they are to keep their head above water.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities